Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Embolization Particle Market by Type (Microspheres, Particles (e.g. PVA Particles, Gelfoam Particles), Drug-eluting Beads (DEBs), Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)), By Application (Uterine Fibroid Embolization, Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH), Liver Tumor Embolization, Trauma Embolization, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Embolization Particle Market by Type (Microspheres, Particles (e.g. PVA Particles, Gelfoam Particles), Drug-eluting Beads (DEBs), Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)), By Application (Uterine Fibroid Embolization, Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH), Liver Tumor Embolization, Trauma Embolization, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 189480 3300 Pharma & Healthcare 377 238 Pages 4.9 (44)
                                          

The global embolization particle market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of benign prostatic hyperplasia (BPH) and uterine fibroid embolization (UFE), growing demand for minimally invasive procedures, and rising adoption of embolic agents in various applications. The microspheres segment accounted for the largest share in the global embolization particle market in 2018, followed by particles segment. The microspheres segment is expected to maintain its dominance throughout the forecast period owing to their ability to be used as an alternative treatment option for various conditions such as BPH and UFE. In terms of application, UFE accounted for the largest share in 2018 due to its high prevalence among women aged 40-50 years old and increasing adoption rates across developed countries such as US and Japan. However, liver tumor embolization (LTE) is projected to grow at a higher CAGR during the forecast period owing to its high incidence rate among men aged 50-60 years old with chronic liver disease or cirrhosis who are more likely than women with uterine fibroids or benign prostatic hyperplasia (BPH) are more likely than women with uterine fibroids or benign prostatic hyperplasia (BPH) are more likely than women with uterine fibroids or benign prostatic hyperplasia (BPH) are more likely than women with uterine fibroids or benign prostatic hyperplasia (BPH).

  1. The market for embolization particles is expected to reach $1,890 million by 2025.
  2. Increasing prevalence of cancer and other diseases will drive the growth of the embolization particle market.
  3. Increasing number of new product launches in the global embolization particle market will fuel its growth.
  4. Growing demand for minimally invasive procedures.

Industry Growth Insights published a new data on “Embolization Particle Market”. The research report is titled “Embolization Particle Market research by Types (Microspheres, Particles (e.g. PVA Particles, Gelfoam Particles), Drug-eluting Beads (DEBs), Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)), By Applications (Uterine Fibroid Embolization, Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH), Liver Tumor Embolization, Trauma Embolization, Other), By Players/Companies Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials B.V., Alicon”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Embolization Particle Market Research Report

By Type

Microspheres, Particles (e.g. PVA Particles, Gelfoam Particles), Drug-eluting Beads (DEBs), Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)

By Application

Uterine Fibroid Embolization, Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH), Liver Tumor Embolization, Trauma Embolization, Other

By Companies

Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials B.V., Alicon

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

238

Number of Tables & Figures

167

Customization Available

Yes, the report can be customized as per your need.


Global Embolization Particle Industry Outlook


Global Embolization Particle Market Report Segments:

The global Embolization Particle market is segmented on the basis of:

Types

Microspheres, Particles (e.g. PVA Particles, Gelfoam Particles), Drug-eluting Beads (DEBs), Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Uterine Fibroid Embolization, Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH), Liver Tumor Embolization, Trauma Embolization, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Sirtex Medical
  2. Merit Medical
  3. Cook Medical
  4. BTG Medical
  5. Boston Scientific Corporation
  6. Terumo Corporation
  7. HENGRUI Medical
  8. INterface BIOmaterials B.V.
  9. Alicon

Global Embolization Particle Market Overview


Highlights of The Embolization Particle Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Microspheres
    2. Particles (e.g. PVA Particles, Gelfoam Particles)
    3. Drug-eluting Beads (DEBs)
    4. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
  1. By Application:

    1. Uterine Fibroid Embolization
    2. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
    3. Liver Tumor Embolization
    4. Trauma Embolization
    5. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Embolization Particle Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Embolization Particle Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


An embolization particle is a small, solid piece of material that is used to block blood flow in an artery or vein.

Some of the key players operating in the embolization particle market are Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials B.V., Alicon.

The embolization particle market is expected to grow at a compound annual growth rate of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Embolization Particle Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Embolization Particle Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Embolization Particle Market - Supply Chain
   4.5. Global Embolization Particle Market Forecast
      4.5.1. Embolization Particle Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Embolization Particle Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Embolization Particle Market Absolute $ Opportunity

5. Global Embolization Particle Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Embolization Particle Market Size and Volume Forecast by Type
      5.3.1. Microspheres
      5.3.2. Particles (e.g. PVA Particles, Gelfoam Particles)
      5.3.3. Drug-eluting Beads (DEBs)
      5.3.4. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Embolization Particle Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Embolization Particle Market Size and Volume Forecast by Application
      6.3.1. Uterine Fibroid Embolization
      6.3.2. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
      6.3.3. Liver Tumor Embolization
      6.3.4. Trauma Embolization
      6.3.5. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Embolization Particle Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Embolization Particle Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Embolization Particle Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Embolization Particle Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Embolization Particle Demand Share Forecast, 2019-2026

9. North America Embolization Particle Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Embolization Particle Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Embolization Particle Market Size and Volume Forecast by Application
      9.4.1. Uterine Fibroid Embolization
      9.4.2. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
      9.4.3. Liver Tumor Embolization
      9.4.4. Trauma Embolization
      9.4.5. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Embolization Particle Market Size and Volume Forecast by Type
      9.7.1. Microspheres
      9.7.2. Particles (e.g. PVA Particles, Gelfoam Particles)
      9.7.3. Drug-eluting Beads (DEBs)
      9.7.4. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Embolization Particle Demand Share Forecast, 2019-2026

10. Latin America Embolization Particle Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Embolization Particle Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Embolization Particle Market Size and Volume Forecast by Application
      10.4.1. Uterine Fibroid Embolization
      10.4.2. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
      10.4.3. Liver Tumor Embolization
      10.4.4. Trauma Embolization
      10.4.5. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Embolization Particle Market Size and Volume Forecast by Type
      10.7.1. Microspheres
      10.7.2. Particles (e.g. PVA Particles, Gelfoam Particles)
      10.7.3. Drug-eluting Beads (DEBs)
      10.7.4. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Embolization Particle Demand Share Forecast, 2019-2026

11. Europe Embolization Particle Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Embolization Particle Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Embolization Particle Market Size and Volume Forecast by Application
      11.4.1. Uterine Fibroid Embolization
      11.4.2. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
      11.4.3. Liver Tumor Embolization
      11.4.4. Trauma Embolization
      11.4.5. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Embolization Particle Market Size and Volume Forecast by Type
      11.7.1. Microsphres
      11.7.2. Particles (e.g. PVA Particles, Gelfoam Particles)
      11.7.3. Drug-eluting Beads (DEBs)
      11.7.4. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Embolization Particle Demand Share, 2019-2026

12. Asia Pacific Embolization Particle Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Embolization Particle Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Embolization Particle Market Size and Volume Forecast by Application
      12.4.1. Uterine Fibroid Embolization
      12.4.2. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
      12.4.3. Liver Tumor Embolization
      12.4.4. Trauma Embolization
      12.4.5. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Embolization Particle Market Size and Volume Forecast by Type
      12.7.1. Microspheres
      12.7.2. Particles (e.g. PVA Particles, Gelfoam Particles)
      12.7.3. Drug-eluting Beads (DEBs)
      12.7.4. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Embolization Particle Demand Share, 2019-2026

13. Middle East & Africa Embolization Particle Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Embolization Particle Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Embolization Particle Market Size and Volume Forecast by Application
      13.4.1. Uterine Fibroid Embolization
      13.4.2. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
      13.4.3. Liver Tumor Embolization
      13.4.4. Trauma Embolization
      13.4.5. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Embolization Particle Market Size and Volume Forecast by Type
      13.7.1. Microspheres
      13.7.2. Particles (e.g. PVA Particles, Gelfoam Particles)
      13.7.3. Drug-eluting Beads (DEBs)
      13.7.4. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Embolization Particle Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Embolization Particle Market: Market Share Analysis
   14.2. Embolization Particle Distributors and Customers
   14.3. Embolization Particle Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Sirtex Medical
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Merit Medical
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Cook Medical
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. BTG Medical
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Boston Scientific Corporation
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Terumo Corporation
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. HENGRUI Medical
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. INterface BIOmaterials B.V.
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Alicon
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us